Record Information |
---|
Version | 1.0 |
---|
Created at | 2022-04-28 06:22:59 UTC |
---|
Updated at | 2022-04-28 06:22:59 UTC |
---|
NP-MRD ID | NP0061626 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | 13beta,29-Dihydroxymilbemycin A3 |
---|
Description | (1'R,2R,4'S,5R,6S,8'S,10'E,12'R,13'R,14'E,20'S,21'R,24'S)-12',21',24'-trihydroxy-11'-(hydroxymethyl)-5,6,13',22'-tetramethyl-3',7',19'-trioxaspiro[oxane-2,6'-tetracyclo[15.6.1.1⁴,⁸.0²⁰,²⁴]Pentacosane]-10',14',16',22'-tetraen-2'-one belongs to the class of organic compounds known as milbemycins. These are a group of macrolides with a structure containing a 16-membered lactone ring fused to a 1,7-dioxaspiroundecane ring system and to either a benzofuran (or hydrogenated derivative thereof). In some cases (e.G. Milbemycin E), the tetrahydrofuranyl ring is missing. Milbemycins can be o-glycosylated at C13 to form Avermectins. Milbemycins are produced by Streptomyces species. 13beta,29-Dihydroxymilbemycin A3 is found in Streptomyces cavourensis and Streptomyces cavourensis SANK 67386. Based on a literature review very few articles have been published on (1'R,2R,4'S,5R,6S,8'S,10'E,12'R,13'R,14'E,20'S,21'R,24'S)-12',21',24'-trihydroxy-11'-(hydroxymethyl)-5,6,13',22'-tetramethyl-3',7',19'-trioxaspiro[oxane-2,6'-tetracyclo[15.6.1.1⁴,⁸.0²⁰,²⁴]Pentacosane]-10',14',16',22'-tetraen-2'-one. |
---|
Structure | C[C@@H]1CC[C@]2(C[C@@H]3C[C@H](C\C=C(CO)\[C@H](O)[C@H](C)\C=C\C=C4/CO[C@H]5[C@H](O)C(C)=C[C@@H](C(=O)O3)[C@]45O)O2)O[C@H]1C InChI=1S/C31H44O9/c1-17-10-11-30(39-20(17)4)14-24-13-23(40-30)9-8-21(15-32)26(33)18(2)6-5-7-22-16-37-28-27(34)19(3)12-25(29(35)38-24)31(22,28)36/h5-8,12,17-18,20,23-28,32-34,36H,9-11,13-16H2,1-4H3/b6-5+,21-8+,22-7+/t17-,18-,20+,23+,24+,25+,26-,27-,28+,30+,31-/m1/s1 |
---|
Synonyms | Not Available |
---|
Chemical Formula | C31H44O9 |
---|
Average Mass | 560.6840 Da |
---|
Monoisotopic Mass | 560.29853 Da |
---|
IUPAC Name | (1'R,2R,4'S,5R,6S,8'S,10'E,12'R,13'R,14'E,16'E,20'S,21'R,24'S)-12',21',24'-trihydroxy-11'-(hydroxymethyl)-5,6,13',22'-tetramethyl-3',7',19'-trioxaspiro[oxane-2,6'-tetracyclo[15.6.1.1^{4,8}.0^{20,24}]pentacosane]-10',14',16',22'-tetraen-2'-one |
---|
Traditional Name | (1'R,2R,4'S,5R,6S,8'S,10'E,12'R,13'R,14'E,16'E,20'S,21'R,24'S)-12',21',24'-trihydroxy-11'-(hydroxymethyl)-5,6,13',22'-tetramethyl-3',7',19'-trioxaspiro[oxane-2,6'-tetracyclo[15.6.1.1^{4,8}.0^{20,24}]pentacosane]-10',14',16',22'-tetraen-2'-one |
---|
CAS Registry Number | Not Available |
---|
SMILES | C[C@@H]1CC[C@]2(C[C@@H]3C[C@H](C\C=C(CO)\[C@H](O)[C@H](C)\C=C\C=C4/CO[C@H]5[C@H](O)C(C)=C[C@@H](C(=O)O3)[C@]45O)O2)O[C@H]1C |
---|
InChI Identifier | InChI=1S/C31H44O9/c1-17-10-11-30(39-20(17)4)14-24-13-23(40-30)9-8-21(15-32)26(33)18(2)6-5-7-22-16-37-28-27(34)19(3)12-25(29(35)38-24)31(22,28)36/h5-8,12,17-18,20,23-28,32-34,36H,9-11,13-16H2,1-4H3/b6-5+,21-8+,22-7+/t17-,18-,20+,23+,24+,25+,26-,27-,28+,30+,31-/m1/s1 |
---|
InChI Key | KYWVCYGVFODUCB-CVYFFTCRSA-N |
---|
Experimental Spectra |
---|
|
| Not Available | Predicted Spectra |
---|
|
| Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 13C NMR Spectrum (1D, 25 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as milbemycins. These are a group of macrolides with a structure containing a 16-membered lactone ring fused to a 1,7-dioxaspiroundecane ring system and to either a benzofuran (or hydrogenated derivative thereof). In some cases (e.G. Milbemycin E), the tetrahydrofuranyl ring is missing. Milbemycins can be o-glycosylated at C13 to form Avermectins. Milbemycins are produced by Streptomyces species. |
---|
Kingdom | Organic compounds |
---|
Super Class | Phenylpropanoids and polyketides |
---|
Class | Macrolides and analogues |
---|
Sub Class | Milbemycins |
---|
Direct Parent | Milbemycins |
---|
Alternative Parents | |
---|
Substituents | - Milbemycin
- Ketal
- Oxane
- Tetrahydrofuran
- Tertiary alcohol
- Secondary alcohol
- Lactone
- Carboxylic acid ester
- Oxacycle
- Organoheterocyclic compound
- Polyol
- Monocarboxylic acid or derivatives
- Ether
- Dialkyl ether
- Carboxylic acid derivative
- Acetal
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Primary alcohol
- Organooxygen compound
- Carbonyl group
- Alcohol
- Aliphatic heteropolycyclic compound
|
---|
Molecular Framework | Aliphatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|